Shuntaro Morikawa

Dr. Shuntaro Morikawa

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
KMKristina G. Maxwell
Kristina G. Maxwell
PAPunn Augsornworawat
Punn Augsornworawat
LVLeonardo Velazco-Cruz
Leonardo Velazco-Cruz
MKMichelle H. Kim
Michelle H. Kim
RARie Asada
Rie Asada
JMJeffrey R. Millman
Jeffrey R. Millman
Patient stem cell–derived β cells corrected for a diabetes-causing variant in WFS1 restore glucose homeostasis when transplanted into diabetic mice.

8 March 2017 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
SMShuntaro Morikawa
Shuntaro Morikawa
TTToshihiro Tajima
Toshihiro Tajima
ANAkie Nakamura
Akie Nakamura
KIKatsura Ishizu
Katsura Ishizu
TATadashi Ariga
Tadashi Ariga

4 May 2020 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
JMJana Mahadevan
Jana Mahadevan
SMShuntaro Morikawa
Shuntaro Morikawa
TYTakuya Yagi
Takuya Yagi
DADamien Abreu
Damien Abreu
SLSimin Lu
Simin Lu
FUFumihiko Urano
Fumihiko Urano
Endoplasmic reticulum (ER) stress-mediated cell death is an emerging target for human chronic disorders, including neurodegeneration and diabetes. However, there is currently no treatment for preventing ER stress-mediated cell death. Here, we show that mesencephalic astrocyte-derived neurotrophic factor (MANF), a neurotrophic factor secreted from ER stressed cells, prevents ER stress-mediated β cell death and enhances β cell proliferation in cell and mouse models of Wolfram syndrome, a prototype of ER disorders. Our results indicate that molecular pathways regulated by MANF are promising therapeutic targets for regenerative therapy of ER stress-related disorders, including diabetes, retinal degeneration, neurodegeneration, and Wolfram syndrome.

Verified
Journal Article
Open access
PDF file
SMShuntaro Morikawa
Shuntaro Morikawa
FUFumihiko Urano
Fumihiko Urano
The endoplasmic reticulum (ER) is a cytosolic organelle that plays an essential role in the folding and processing of new secretory proteins, including insulin. The pathogenesis of diabetes, a group of metabolic disorders caused by dysfunctional insulin secretion (Type 1 diabetes, T1DM) or insulin sensitivity (Type 2 diabetes, T2DM), is known to involve the excess accumulation of “poorly folded proteins”, namely, the induction of pathogenic ER stress in pancreatic β-cells. ER stress is known to contribute to the dysfunction of the insulin-producing pancreatic β-cells. T1DM and T2DM are multifactorial diseases, especially T2DM; both environmental and genetic factors are involved in their pathogenesis, making it difficult to create experimental disease models. In recent years, however, the development of induced pluripotent stem cells (iPSCs) and other regenerative technologies has greatly expanded research capabilities, leading to the development of new candidate therapies. In this review, we will discuss the mechanism by which dysregulated ER stress responses contribute to T2DM pathogenesis. Moreover, we describe new treatment methods targeting protein folding and ER stress pathways with a particular focus on pivotal studies of Wolfram syndrome, a monogenic form of syndromic diabetes caused by pathogenic variants in the WFS1 gene, which also leads to ER dysfunction.

19 February 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
KAKikuko Amo-Shiinoki
Kikuko Amo-Shiinoki
Katsuya TanabeKatsuya Tanabe
Katsuya Tanabe
WNWataru Nishimura
Wataru Nishimura
MHMasayuki Hatanaka
Masayuki Hatanaka
MKManabu Kondo
Manabu Kondo
YTYukio Tanizawa
Yukio Tanizawa
Insulin-dependent diabetes in patients with Wolfram syndrome (WS; OMIM 222300) has been linked to endoplasmic reticulum (ER) stress caused by WFS1 gene mutations. However, the pathological process of ER stress–associated β cell failure remains to be fully elucidated. Our results indicate loss of β cell lineage and subsequent dedifferentiation as the mechanisms underlying functional and mass deficits in WS. An immunohistochemical analysis of human pancreatic sections from deceased individuals with WS revealed a near-complete loss of β cells and subsequent decrease in α cells, suggesting loss of endocrine function. Wfs1 -deficient mice displayed dysfunction, gradual loss, and dedifferentiation of β cells, leading to permanent hyperglycemia. Impairment of the β cell lineage was observed after weaning, leading to the mixed phenotype of insulin- and glucagon-producing cells in a subset of the lineage-traced β cells. Islets of Wfs1 -deficient mice increased the number of dedifferentiated cells that maintained general endocrine features but were no longer reactive with antisera against pancreatic hormones. Mechanistically, Wfs1 -null islets had a lower adenosine triphosphate content and impaired oxidative glycolysis, although mitochondrial oxidative function was maintained. The functional and metabolic alterations of WS β cells were recovered by deletion of thioredoxin-interacting protein (Txnip), an ER stress–induced protein up-regulated in Wfs1 deficiency. Txnip deletion preserved functional β cells and prevented diabetes progression in Wfs1 -deficient mice. Together, this study deciphered pathological mechanisms of β cell dedifferentiation in β cell failure and has implications for Txnip inhibition in WS therapy.

1 January 2018 in Case Reports in Pediatrics
Verified
Journal Article
Open access
PDF file
NNNoriko Namatame-Ohta
Noriko Namatame-Ohta
SMShuntaro Morikawa
Shuntaro Morikawa
ANAkie Nakamura
Akie Nakamura
KMKumihiro Matsuo
Kumihiro Matsuo
MNMasahide Nakajima
Masahide Nakajima
TTToshihiro Tajima
Toshihiro Tajima
Almost 90% of nephrogenic diabetes insipidus (NDI) is caused by mutations in the arginine vasopressin receptor 2 gene ( AVPR2 ) on the X chromosome. Herein, we reported clinical and biochemical parameters in four cases of three unrelated Japanese families and analyzed the status of the AVPR2. Two of the four patients had poor weight gain. However, in the male and female sibling cases, neither had poor weight gain while toddlers, but in the male sibling, episodes of recurrent fever, polyuria, and polydipsia led to the diagnosis of NDI at 4 years of age. Analysis of AVPR2 identified two nonsense mutations (c.299_300insA; p.K100KfsX91 and c.296G > A; p.W99X) and one missense mutation (c.316C > T; p.R106C). These mutations were previously reported. The patient with c.316C > T; p.R106C had milder symptoms consistent with previous reports. Of the familial cases, the sister was diagnosed as having NDI, but a skewed X‐inactivation pattern in her peripheral blood lymphocytes was not identified. In conclusion, our study expands the spectrum of phenotypes and characterized mutations in AVPR2 in NDI.